Zomedica Corp. (NASDAQ:ZOM) | Finanzwire

Basculer en Français

8306	Companies
115272	Keywords
55558	Articles
62591	Press releases

Home
Companies
Zomedica Corp.

BRIEF

published on 05/02/2024 at 12:35, 6 months 20 days ago

Zomedica Bolsters Intellectual Property with New Patents for TRUFORMA Platform

Zomedica Veterinary Health Patents TRUFORMA Diagnostic Platform
PRESS RELEASE

published on 05/02/2024 at 12:30, 6 months 20 days ago

Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Zomedica announces issuance of three new patents for TRUFORMA diagnostic platform, enhancing veterinary care with innovative technology and expanding intellectual property portfolio

Innovation Veterinary Care Zomedica Patents TRUFORMA
BRIEF

published on 04/30/2024 at 12:35, 6 months 22 days ago

Zomedica to Present Q1 2024 Financial Results and Business Update on May 9th

Financial Results Conference Call Business Update Zomedica Q1 2024
PRESS RELEASE

published on 04/30/2024 at 12:30, 6 months 22 days ago

Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
Zomedica Corp. to discuss Q1 2024 financial results on May 9th, 2024, in a conference call and webcast. Company focuses on veterinary health products for animals

Conference Call Webcast Zomedica Corp. Veterinary Health Q1 2024 Financial Results
BRIEF

published on 04/09/2024 at 12:35, 7 months 13 days ago

Zomedica to Present at Noble Capital Markets Virtual Healthcare Conference

Zomedica Corp. Veterinary Health Noble Capital Markets Virtual Healthcare Conference Equity Conference Presentation
PRESS RELEASE

published on 04/09/2024 at 12:30, 7 months 13 days ago

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Zomedica Corp. to present at Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference. CEO Larry Heaton to lead a fireside Q&A session with live audience participation

Veterinary Health Company Zomedica Corp. Noble Capital Markets Virtual Healthcare Equity Conference CEO Larry Heaton
BRIEF

published on 04/01/2024 at 22:10, 7 months 20 days ago

Zomedica Reports Record Fourth Quarter and Annual Revenue Growth in 2023

Financial Results Revenue Growth Zomedica Veterinary Health Diagnostic Products
PRESS RELEASE

published on 04/01/2024 at 22:05, 7 months 20 days ago

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Zomedica Corp. reports consolidated financial results for Q4 and full year 2023, showing significant revenue growth and progress. CEO Larry Heaton highlights momentum and strategic acquisitions for future growth

Financial Results Revenue Growth Acquisitions 2023 Zomedica Corp.
BRIEF

published on 03/20/2024 at 11:35, 8 months 2 days ago

Zomedica Announces Q4 and Full Year 2023 Financial Results Conference

Financial Results Conference Call 2023 Performance Zomedica Veterinary Health
PRESS RELEASE

published on 03/20/2024 at 11:30, 8 months 2 days ago

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals

Financial Results Conference Call Companion Animals Zomedica Corp. Veterinary Health

Accesswire

Published on 11/22/2024 at 14:05, 18 minutes ago

First Gas-To-Power Data Centre Connection
Published on 11/22/2024 at 14:00, 23 minutes ago

Clear Start Tax Warns Taxpayers About Upcoming IRS Collection Changes in 2025
Published on 11/22/2024 at 14:00, 23 minutes ago

Frequency Exchange Welcomes Former NHL Star and Current President of the Boston Bruins Cam Neely to Its Advisory Board
Published on 11/22/2024 at 14:00, 23 minutes ago

Results of 2024 Annual General Meeting
Published on 11/22/2024 at 13:30, 53 minutes ago

Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 14:01, 21 minutes ago

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
Published on 11/22/2024 at 14:00, 23 minutes ago

Wim de Pundert appointed as CEO and CFO of Knaus Tabbert AG
Published on 11/22/2024 at 13:55, 27 minutes ago

EQS-Adhoc: Knaus Tabbert AG: Wim de Pundert appointed as CEO and CFO of Knaus Tabbert AG
Published on 11/22/2024 at 11:54, 2 hours 29 minutes ago

PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 2 hours 38 minutes ago

How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution

Les Echos

Published on 11/21/2024 at 06:58, 1 day 7 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 19 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 20 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 20 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE